Pro and Con Editorials

Patients with high-risk acute promyelocytic leukemia need maintenance therapy for one year - the CONS

Institute of Haematology, Royal Prince Alfred Hospital, Camperdown, NSW, Australia; Faculty of Medicine and Health, University of Sydney, Sydney, NSW
Haematologica Early view Apr 3, 2025 https://doi.org/10.3324/haematol.2025.287418